Literature DB >> 25132905

Reversible cerebral vasoconstriction syndrome and nonaneurysmal subarachnoid hemorrhage.

Miguel A Barboza1, Alberto Maud2, Gustavo J Rodriguez3.   

Abstract

BACKGROUND: Reversible cerebral vasoconstriction syndrome was first described by Call, Fleming, and colleagues. Clinically this entity presents acutely, with severe waxing and waning headaches ("thunderclap"), and occasional fluctuating neurological signs. CASE
PRESENTATION: We present four subsequent cases of patients with severe thunderclap headache and brain tomography with evidence of subarachnoid hemorrhage. The brain angiogram showed no aneurysm but intracranial vasculopathy consistent with multiple areas of stenosis and dilatation (angiographic beading) in different territories.
CONCLUSION: Neurologists should be aware of Call Fleming syndrome presenting with severe headache and associated convexity subarachnoid hemorrhage. After other diagnoses are excluded, patients can be reassured about favorable prognosis with symptomatic management. ABBREVIATIONS: RCVSReversible cerebral vasoconstriction syndromeCTComputed tomographySAHSubarachnoid hemorrhageMRMagnetic resonanceCTAComputed tomography angiographyMRAMagnetic resonance angiography.

Entities:  

Keywords:  Call Fleming syndrome; cerebral vasoconstriction; nonaneurysmatic subarachnoid hemorrhage; thunderclap headache

Year:  2014        PMID: 25132905      PMCID: PMC4132938     

Source DB:  PubMed          Journal:  J Vasc Interv Neurol        ISSN: 1941-5893


  7 in total

Review 1.  Narrative review: reversible cerebral vasoconstriction syndromes.

Authors:  Leonard H Calabrese; David W Dodick; Todd J Schwedt; Aneesh B Singhal
Journal:  Ann Intern Med       Date:  2007-01-02       Impact factor: 25.391

Review 2.  Reversible cerebral segmental vasoconstriction.

Authors:  G K Call; M C Fleming; S Sealfon; H Levine; J P Kistler; C M Fisher
Journal:  Stroke       Date:  1988-09       Impact factor: 7.914

3.  Diffuse cerebral vasoconstriction (Call-Fleming syndrome) and stroke associated with antidepressants.

Authors:  Olga Noskin; Elham Jafarimojarrad; Richard B Libman; Jeffrey L Nelson
Journal:  Neurology       Date:  2006-07-11       Impact factor: 9.910

4.  Cerebral vasoconstriction and stroke after use of serotonergic drugs.

Authors:  A B Singhal; V S Caviness; A F Begleiter; E J Mark; G Rordorf; W J Koroshetz
Journal:  Neurology       Date:  2002-01-08       Impact factor: 9.910

5.  Reversible cerebral vasoconstriction syndrome presenting as subarachnoid hemorrhage, reversible posterior leukoencephalopathy, and cerebral infarction.

Authors:  Kazuyuki Noda; Jiro Fukae; Kenji Fujishima; Kentaro Mori; Takao Urabe; Nobutaka Hattori; Yasuyuki Okuma
Journal:  Intern Med       Date:  2011-06-01       Impact factor: 1.271

6.  Call-Fleming syndrome associated with subarachnoid haemorrhage: three new cases.

Authors:  R R Moustafa; C M C Allen; J-C Baron
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-12-12       Impact factor: 10.154

7.  The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients.

Authors:  Anne Ducros; Monique Boukobza; Raphaël Porcher; Mariana Sarov; Dominique Valade; Marie-Germaine Bousser
Journal:  Brain       Date:  2007-11-19       Impact factor: 13.501

  7 in total
  1 in total

1.  Spontaneous intracranial hemorrhage presenting in a patient with vitamin K deficiency and COVID-19: illustrative case.

Authors:  Nathaniel R Ellens; Howard J Silberstein
Journal:  J Neurosurg Case Lessons       Date:  2021-03-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.